Prelude Capital Management’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-79,155
| Closed | -$293K | – | 1710 |
|
|
2017
Q4 | $293K | Buy |
+79,155
| New | +$293K | 0.02% | 470 |
|
|
2017
Q1 | – | Sell |
-100
| Closed | – | – | 1899 |
|
|
2016
Q4 | $0 | Buy |
+100
| New | – | ﹤0.01% | 1875 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 1884 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 2145 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 2139 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 2089 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 2037 |
|
|
2013
Q4 | – | Sell |
-1,515
| Closed | -$19K | – | 1941 |
|
|
2013
Q3 | $19K | Buy |
+1,515
| New | +$19K | ﹤0.01% | 1100 |
|